Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
Spyre Therapeutics (SYRE) has experienced a notable pullback in recent trading, with the stock slipping roughly 2% to $74.14. This decline brings the shares closer to their established support level near $70.43, while resistance remains around $77.85. Volume over the past several sessions has been m
Spyre Therapeutics (SYRE) Stock: Down -2.00%, Support Test at $70.43 2026-05-15 - High Volume Stocks
SYRE - Stock Analysis
4892 Comments
1813 Likes
1
Mekhiah
Active Contributor
2 hours ago
As a student, this wouldâve been super helpful earlier.
đ 99
Reply
2
Altaf
Returning User
5 hours ago
Investor focus remains on upcoming economic data releases, which could affect short-term market sentiment.
đ 184
Reply
3
Abdulhamid
Loyal User
1 day ago
Thatâs some âwowâ energy. âĄ
đ 123
Reply
4
Joyful
Insight Reader
1 day ago
Provides actionable insights without being overly detailed.
đ 57
Reply
5
Daking
New Visitor
2 days ago
Did you just bend reality with that? đ
đ 166
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.